Company intelligence / Profile preview

Arabian Eagle Manufacturing

Saudi Arabia

Ownership: Private
Development stage: Other

Overview

Arabian Eagle Manufacturing, via its JV CoMira Diagnostics, will manufacture, distribute, and commercialize molecular diagnostic tests (PCR-based) across KSA and MENA; clinical evaluations for new multiplex infectious disease assays (e.g., tuberculosis, HPV, respiratory viruses) are expected by end of 2025

Therapeutic areas: Infectious Diseases
Modalities: PCR diagnostics (Polymerase Chain Reaction-based tests)
Industry: Molecular Diagnostics

Partnerships

Co-Diagnostics (JV partner for CoMira Diagnostics)

Beyond the preview

Go deeper on Arabian Eagle Manufacturing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arabian Eagle Manufacturing.

Explore the full profile